U.S. Biotech Industry Analysis
UpdatedAug 21, 2024
DataAggregated Company Financials
Companies555
- 7D3.5%
- 3M4.5%
- 1Y14.9%
- YTD6.2%
Over the last 7 days, the Biotech industry has risen 3.5%, driven by gains from AbbVie of 2.6%. In the same time, Arcutis Biotherapeutics was down 12%. In the last 12 months, the industry was up 15%. As for the next few years, earnings are expected to grow by 30% per annum.
Industry Valuation and Performance
Has the U.S. Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 21 Aug 2024 | US$905.2b | US$113.2b | -US$35,832,221,284.65 | 22.9x | -25.3x | 8x |
| Fri, 19 Jul 2024 | US$1.2t | US$164.5b | -US$28,050,002,699.28 | 29x | -43.2x | 7.4x |
| Sun, 16 Jun 2024 | US$1.2t | US$164.4b | -US$28,071,754,707.37 | 27.3x | -41.2x | 7x |
| Tue, 14 May 2024 | US$1.1t | US$164.7b | -US$26,999,224,352.94 | 23.2x | -41.7x | 6.8x |
| Thu, 11 Apr 2024 | US$1.1t | US$164.3b | -US$23,371,324,513.62 | 21.4x | -48.7x | 6.9x |
| Sat, 09 Mar 2024 | US$1.2t | US$167.3b | -US$22,121,973,439.03 | 19x | -54x | 7.1x |
| Mon, 05 Feb 2024 | US$1.4t | US$203.9b | -US$24,425,425,728.00 | 19.2x | -58.9x | 7.1x |
| Wed, 03 Jan 2024 | US$1.4t | US$204.8b | -US$22,201,360,571.00 | 21x | -63.9x | 6.9x |
| Fri, 01 Dec 2023 | US$1.2t | US$204.7b | -US$22,039,871,274.00 | 18.5x | -56x | 6x |
| Sun, 29 Oct 2023 | US$1.2t | US$206.6b | -US$15,166,070,486.00 | 16.3x | -77.7x | 5.7x |
| Tue, 26 Sep 2023 | US$1.3t | US$207.4b | -US$12,899,236,949.00 | 17x | -97.7x | 6.1x |
| Thu, 24 Aug 2023 | US$1.3t | US$207.6b | -US$12,449,828,498.00 | 17.5x | -103.1x | 6.2x |
| Sat, 22 Jul 2023 | US$1.2t | US$186.5b | -US$16,009,709,300.00 | 12.8x | -72x | 6.2x |
| Mon, 19 Jun 2023 | US$1.2t | US$186.3b | -US$16,034,836,469.00 | 12.1x | -72.3x | 6.2x |
| Wed, 17 May 2023 | US$1.2t | US$191.6b | -US$12,334,188,018.00 | 13.3x | -93.3x | 6x |
| Fri, 14 Apr 2023 | US$1.2t | US$198.6b | -US$3,203,316,182.00 | 14.2x | -369.1x | 6x |
| Sun, 12 Mar 2023 | US$1.1t | US$199.3b | -US$4,751,094,936.00 | 14.9x | -230.3x | 5.5x |
| Tue, 07 Feb 2023 | US$1.2t | US$202.1b | US$1.8b | 16.4x | 644.8x | 5.7x |
| Thu, 05 Jan 2023 | US$1.2t | US$203.3b | US$1.6b | 14.4x | 711.3x | 5.7x |
| Sat, 03 Dec 2022 | US$1.2t | US$202.6b | US$1.4b | 15.1x | 843.3x | 5.8x |
| Mon, 31 Oct 2022 | US$1.1t | US$205.9b | US$7.4b | 14.3x | 148.7x | 5.3x |
| Wed, 28 Sep 2022 | US$1.0t | US$205.7b | US$5.5b | 13.9x | 186.2x | 4.9x |
| Fri, 26 Aug 2022 | US$1.1t | US$206.2b | US$7.2b | 15.9x | 148x | 5.2x |
| Sun, 24 Jul 2022 | US$1.1t | US$211.4b | US$11.3b | 15.8x | 93.8x | 5x |
| Tue, 21 Jun 2022 | US$952.1b | US$212.4b | US$11.0b | 14.8x | 86.4x | 4.5x |
| Thu, 19 May 2022 | US$1.0t | US$212.1b | US$10.7b | 14.6x | 93.9x | 4.7x |
| Sat, 16 Apr 2022 | US$1.3t | US$226.7b | US$14.9b | 18.7x | 85.9x | 5.6x |
| Mon, 14 Mar 2022 | US$1.2t | US$222.1b | US$10.5b | 18.7x | 114.3x | 5.4x |
| Wed, 09 Feb 2022 | US$1.3t | US$216.3b | US$6.5b | 22x | 194.2x | 5.9x |
| Fri, 07 Jan 2022 | US$1.3t | US$212.0b | US$2.7b | 25.8x | 493.9x | 6.4x |
| Sun, 05 Dec 2021 | US$1.4t | US$211.9b | US$3.1b | 25.1x | 460.6x | 6.6x |
| Tue, 02 Nov 2021 | US$1.5t | US$196.7b | -US$3,039,047,507.00 | 26.5x | -501.1x | 7.7x |
| Thu, 30 Sep 2021 | US$1.5t | US$196.3b | -US$2,433,800,371.00 | 24.6x | -623.6x | 7.7x |
| Sat, 28 Aug 2021 | US$1.6t | US$197.0b | -US$1,734,385,785.58 | 22x | -917.7x | 8.1x |
Price to Earnings Ratio
-917.7x
Current Industry PE
- Investors are optimistic on the American Biotechs industry, and appear confident in long term growth rates.
- The 3-year average PS ratio of 6.2x is lower than the industry's current PS ratio of 8.0x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have deteriorated over the last three years.
- Revenues have also declined 17% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Trends
Which industries have driven the changes within the U.S. Healthcare industry?
| US Market | 3.06% | |
| Healthcare | 2.31% | |
| Biotech | 3.55% | |
| Biotech | 3.55% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ABBV AbbVie | US$196.15 | 2.6% +US$8.7b | 32.3% | PE65.4x | |
| VRTX Vertex Pharmaceuticals | US$487.37 | 4.2% +US$5.1b | 39.1% | PS12.2x | |
| REGN Regeneron Pharmaceuticals | US$1.19k | 2.9% +US$3.7b | 41.8% | PE29.8x | |
| AMGN Amgen | US$328.55 | 1.6% +US$2.7b | 27.5% | PE56.4x | |
| SGEN Seagen | US$228.74 | 4.5% +US$1.8b | 76.5% | PS18.8x |
